Imperial College Healthcare NHS Trust - Hammersmith Hospital
London, Greater London, W12 0HS, United Kingdom
Location status: Recruiting
NCT Number: NCT04014140
The expected outcome of better and improved patency of bypass grafts and its direct relation to pre-operative iFR measurements of stenosis as compared to direct visual physiology of stenosis in the coronary angiogram.
To establish the correlation between the use of intracoronary physiology and improved graft patency at 12 months for patients undergoing CABG surgery.
It is a minimum of 28 and a maximum of 100 patients single-centre proof or concept/ observational study/ pilot study.
Interested in participating?
Request Info25 year–80 year
All sexes
Observational
London, Greater London, W12 0HS, United Kingdom
Location status: Recruiting
Patients suffering from coronary artery disease undergo coronary artery bypass grafting surgery (CABG) as the standard of care. The selection of which vessels to bypass is usually at the discretion of the surgeon forming an opinion based on the pre-operative angiographic imaging. Intra-coronary physiology (iFR measurements) is more accurate to determine the level of damage to the coronary arteries; however, currently it is not used for CABG pre-assessment, but only for percutaneous intervention also known as stenting as it has been shown to improve outcomes. Although, the use of intracoronary physiology has not been extensively studied or validated in patients undergoing CABG.
Patients with multi-vessel coronary artery disease (CAD) who are planned for surgical revascularization with coronary artery bypass grafting (CABG), will have iFR measurement taken during invasive coronary angiography as part of standard care, they will undergo CABG and will have echocardiography at 3 months and computed tomography coronary angiography (CTCA) at 12 months.
Early graft failure will be assessed by the presentation of any clinical symptoms, major adverse cardiovascular and cerebrovascular events (MACCE) and echocardiography at 3 months. The endpoint will be graft patency as assessed by CT coronary angiography at 12 months.
Anticipated recruitment is 12-24 months. Follow-up with echocardiography at 3 months and a CTCA at 12 months. Quality of Life questionnaire will be completed by the patient at 3 and 12 months during the follow-up appointment.
Patients will continue on optimal medical therapy. Clinic visit and quality of life scale questionnaires will be recorded at 3 and 12 months and echocardiography will be assessed at 3 months. Graft patency at 12 months will be assessed with a CT coronary angiography.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients with MVCAD will undergo CABG as per standard of care.
Time frame: 12 months
The primary endpoint will be graft patency as assessed by CT coronary angiography at 12 months.
Time frame: 3 and 12 months
Patient's view in their quality of life
Time frame: 12 months
Assessed by the presentation of clinical symptoms and echocardiography during a follow-up visit at 3 months or anytime within 12 months.
Time frame: 12 months
Patient undergoing repeat reintervention
Time frame: 12 months
Assessed by the presentation of clinical symptoms, echocardiography during a follow-up visit at 3 months or anytime within 12 months and in addition, evidence of percutaneous or surgical revascularisation within the last 12 months.
Time frame: 12 months
Assessed by the presentation of clinical symptoms during a follow-up visit at 3 and 12 months or anytime within 12 months.
Time frame: 3 months
Cardiac functional assessment at 3 months post-opereatively
Time frame: 12 months
Patient deceased
Time frame: 12 months
Patient deceased
Interested in participating?
Request InfoPrakash Punjabi
Other
Long-term Graft Patency Outcomes of LIMA-LAD Post-CABG Surgery Based on iFR Measurements.
Acronym: iCABG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04674449
Angina Attacks, Angina Pectoris
Cork, Ireland
View Trial DetailsNCT03674255
Angina Pectoris, Arterial Occlusive Diseases
View Trial DetailsNCT04901767
Arterial Occlusive Diseases, Arteriosclerosis
Norwich, Norfolk, United Kingdom
View Trial DetailsNCT04193475
Angina Pectoris, Arterial Occlusive Diseases
Cottingham, United Kingdom
View Trial Details